Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Will move its corporate ventures office from Minneapolis to Maastricht, The Netherlands before the end of the year, allowing Medtronic "to take advantage of a more favorable environment for medical innovation overseas," the company said. The office, headed by VP Michael Baker, directs development, regulatory affairs and pilot production for Medtronic's newest medical therapies, including projects in cardiomyoplasty, voiding/incontinence dysfunction and upper airway dysfunction. Just a "handful" of Medtronic's 10,000+ employees will make the move, the company said